(PharmaNewsWire.Com, July 30, 2019 ) The factors driving market growth include technological advancements in AV software such as integration of PACS & AV tools, improved diagnostic interpretation with AV tools, rising prevalence of target diseases, and growing demand for advanced diagnostic procedures.
The global advanced visualization market is expected to reach USD 3.19 Billion by 2021 from USD 1.89 Billion in 2016, growing at a CAGR of 11.0% from 2016 to 2021.
Market Dynamics
+ Drivers
+ Advancements in AV Software Such as Integration of Pacs & AV Tools
+ Technological Advancements in the Field of AV Technology Leading to Improved Data Interpretation
+ Rising Prevalence of Target Diseases Coupled With Growing Geriatric Population
+ Need for Efficient and Early Diagnosis of Disease
+ Increasing Awareness of Benefits Offered By AV Tools in Disease Diagnosis
The advanced visualization market is classified into hardware & software and services. In 2016, the hardware and software segment is estimated to account for the largest share of the market owing to factors such as the development of technologically advanced software, rising adoption of AV solutions in hospitals and imaging centers, and rising focus of healthcare organizations to streamline and increase workflow efficiency.
The market is segmented into enterprise-wide thin client-based solutions and stand-alone workstation-based solutions. In 2016, the enterprise-wide thin client-based solutions is expected to account for the largest share of the market due to offered benefits such as enhanced data storage capacity, data transfer capabilities, multi-user interface, streamlined analysis, and centralized post-processing solutions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
